Previous issue | Volume 92 | ESPE2019

58th Annual ESPE meeting

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

Card image cap
The theme of this year’s meeting is Variety and Variation in Paediatric Endocrinology. Join us in Vienna to explore the diversity we encounter in our discipline and the care that we have to exercise when using the term “normality”. Whilst gaining an update on the latest treatments, clinical best practice and cutting edge research in the field of paediatric endocrinology.

Poster Category 1

Growth and Syndromes (to include Turner Syndrome) (1)

Tall Stature and Macrodactyly of the Great Toes Due to a Novel Mutation in the Natriuretic Peptide Receptor-2 Gene
1Leiden University Medical Centre, Leiden, Netherlands. 2Haga Hospital / Juliana Children's Hospital, The Hague, Netherlands
hrp0092p1-223
The Phenotypic Spectrum of Kabuki Syndrome in Patients of Chinese Descent
1Shanghai Children's Medical Center, Shanghai, China. 2Shenzhen Children's Hospital, Shenzhen, China. 3Boston Children's Hospital, Boston, USA. 4Broad Institute of MIT and Harvard University, Cambridge, USA
hrp0092p1-225
Response to Growth Hormone in Very Young Children (® International Outcome Study and ANSWER Program
1Department of Pediatric Endocrinology, University Children's Hospital, Saarland University Medical Center, Homburg, Germany. 2Pediatric Endocrinology, University of Minnesota Masonic Children's Hospital, Minneapolis, USA. 3Novo Nordisk Inc., Plainsboro, USA. 4Global Medical Affairs, Novo Nordisk Health Care AG, Zurich, Switzerland. 5Hôpital Universitaire Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris Université Paris Descartes, INSERM U1016, Institut IMAGINE, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Dévelopement, Paris, France. 6Department of Pediatrics, Thomas Jefferson University, Philadelphia, USA
hrp0092p1-226
Latest Results From PATRO Children, a Multi-Centre, Observational Study of the Long-Term Safety and Effectiveness of Omnitrope® in Children Requiring Growth Hormone Treatment
1Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton, United Kingdom. 2Department of Paediatric Endocrinology, University of Leipzig Medical School, Leipzig, Germany. 3Patient Area Endocrinology and Nephrology, Inflammation and Infection Theme, Karolinska University Hospital, Stockholm, Sweden. 4Department of Clinical Science/Paediatrics, Umeå University, Umeå, Sweden. 5Department of Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, Ljubljana, Slovenia. 6Sandoz GmbH, Holzkirchen, Germany
hrp0092p1-227
Broadening of the Phenotypic Spectrum of Coats Plus Syndrome: A Patient Presenting with Extreme Short Stature as a Hallmark Feature
1Institute of Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile. 2Dept of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands. 3Dept of Paediatrics, Leiden University Medical Center, Leiden, Netherlands
hrp0092p1-228
Prognostic Factors of the Growth Hormone Therapy Effectiveness in Children with Turner Syndrome
1Belarusian State Medical University, Minsk, Belarus. 2The State Center for Medical Rehabilitation, Minsk, Belarus
hrp0092p1-230
Height and Weight Dynamics in Preschool Boys with Constitutional Delay of Growth and Puberty
1Vestische children´s hospital, Datteln, Germany. 2Children`s Hospital, Tübingen, Germany
hrp0092p1-231
Two Chinese Children with FBN1-Related Acromelic Dysplasia
Department of Pediatrics, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China
hrp0092p1-232